Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Olsen

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
International Journal of Radiation Oncology, Biology, Physics|May 21, 2020
A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive RecurrencesCorey Speers, S Laura Chang, Andrea Pesch, et al.
Molecular Cancer Therapeutics|August 16, 2019
PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing RadiationAnna R Michmerhuizen, Andrea M Pesch, Leah Moubadder, et al.
NPJ Breast Cancer|August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancerCorey Speers, Shuang G Zhao, Ben Chandler, et al.
Frontiers in Endocrinology|March 3, 2020
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer CellsAnna R Michmerhuizen, Benjamin Chandler, Eric Olsen, et al.
The Journal of Clinical Investigation|January 22, 2020
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombinationBenjamin C Chandler, Leah Moubadder, Cassandra L Ritter, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
International Journal of Radiation Oncology, Biology, Physics|May 21, 2020
A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive RecurrencesCorey Speers, S Laura Chang, Andrea Pesch, et al.
Molecular Cancer Therapeutics|August 16, 2019
PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing RadiationAnna R Michmerhuizen, Andrea M Pesch, Leah Moubadder, et al.
NPJ Breast Cancer|August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancerCorey Speers, Shuang G Zhao, Ben Chandler, et al.
Frontiers in Endocrinology|March 3, 2020
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer CellsAnna R Michmerhuizen, Benjamin Chandler, Eric Olsen, et al.
The Journal of Clinical Investigation|January 22, 2020
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombinationBenjamin C Chandler, Leah Moubadder, Cassandra L Ritter, et al.
Pageof 4